We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+8.92%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$19.5B
AUM Growth
+$5.19B
(+36%)
Cap. Flow
+$4.12B
Cap. Flow
% of AUM
21.08%
Top 10 Holdings %
Top 10 Hldgs %
20.25%
Holding
3,398
New
1,285
Increased
656
Reduced
281
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$224M |
| 2 |
PayPal
PYPL
|
+$220M |
| 3 |
Kroger
KR
|
+$154M |
| 4 |
Zillow
Z
|
+$133M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$189M |
| 2 |
Freeport-McMoran
FCX
|
+$176M |
| 3 |
AbbVie
ABBV
|
+$171M |
| 4 |
Booking.com
BKNG
|
+$155M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 19.46% |
| 2 | Healthcare | 11.27% |
| 3 | Materials | 10.17% |
| 4 | Technology | 7.72% |
| 5 | Consumer Discretionary | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
AB InBev
BUD
$162B
| $879K | ﹤0.01% |
+14,644
| New | +$786K |
|
702
Tyson Foods
TSN
$21.5B
| $878K | ﹤0.01% |
14,107
-2,351
| -14% | -$153K |
|
|
TMHC
703
DELISTED
Taylor Morrison
TMHC
| $876K | ﹤0.01% |
+28,870
| New | +$805K |
|
704
Kinetik
KNTK
$3.77B
| $871K | ﹤0.01% |
26,321
+1,425
| +6% | +$48.5K |
|
|
SYNH
705
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $866K | ﹤0.01% |
+23,618
| New | +$934K |
|
706
Silicon Laboratories
SLAB
$7.17B
| $865K | ﹤0.01% |
+6,377
| New | +$838K |
|
|
CADE
707
DELISTED
Cadence Bank
CADE
| $862K | ﹤0.01% |
+34,968
| New | +$938K |
|
708
Adient
ADNT
$1.69B
| $858K | ﹤0.01% |
24,733
+14,229
| +135% | +$498K |
|
709
Bank OZK
OZK
$5.63B
| $850K | ﹤0.01% |
+21,214
| New | +$911K |
|
710
GlobalFoundries
GFS
$25.9B
| $841K | ﹤0.01% |
+15,600
| New | +$912K |
|
711
Synaptics
SYNA
$4.17B
| $833K | ﹤0.01% |
8,751
+3,721
| +74% | +$358K |
|
712
Kohl's
KSS
$2.09B
| $830K | ﹤0.01% |
32,871
+22,551
| +219% | +$639K |
|
713
Bank of Hawaii
BOH
$3.16B
| $828K | ﹤0.01% |
+10,670
| New | +$827K |
|
714
NextDecade
NEXT
$1.71B
| $823K | ﹤0.01% |
166,611
+43,312
| +35% | +$249K |
|
715
Arrowhead Research
ARWR
$12.1B
| $823K | ﹤0.01% |
20,290
+8,793
| +76% | +$291K |
|
716
Leggett & Platt
LEG
$1.4B
| $819K | ﹤0.01% |
+25,406
| New | +$855K |
|
717
Eastman Chemical
EMN
$7.67B
| $818K | ﹤0.01% |
10,039
+9,788
| +3,900% | +$789K |
|
718
Sensient Technologies
SXT
$5.26B
| $814K | ﹤0.01% |
+11,162
| New | +$800K |
|
719
Ormat Technologies
ORA
$5.81B
| $808K | ﹤0.01% |
+9,343
| New | +$839K |
|
720
Goodyear
GT
$2.1B
| $806K | ﹤0.01% |
79,395
+60,175
| +313% | +$657K |
|
721
Celsius Holdings
CELH
$7.4B
| $804K | ﹤0.01% |
+23,190
| New | +$756K |
|
|
TXNM
722
TXNM Energy Inc
TXNM
$6.41B
| $803K | ﹤0.01% |
+16,450
| New | +$783K |
|
723
SLM Corp
SLM
$4.77B
| $796K | ﹤0.01% |
+47,946
| New | +$786K |
|
724
Hancock Whitney
HWC
$6.21B
| $795K | ﹤0.01% |
+16,420
| New | +$849K |
|
|
GTLS
725
DELISTED
Chart Industries
GTLS
| $792K | ﹤0.01% |
6,872
+4,332
| +171% | +$696K |
|
Similar funds
SAM
Pacer Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Pacer Advisors held 3,398 positions worth $19.5B, up 36% from $14.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Pacer Advisors deployed $4.12B of net new capital in Q4 2022, opening 1,285 new positions and adding to 656 existing holdings. Its largest new stake was Woodside Energy: 805,273 shares worth $19.5M.
By sector, the portfolio is most concentrated in Energy at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $189M trimmed.
- Pacer Advisors's largest Q4 2022 buy was Woodside Energy: 805,273 shares worth $19.5M.
- Pacer Advisors added most to EOG Resources in Q4 2022, an estimated $224M increase.
- Pacer Advisors's biggest Q4 2022 reduction was Regeneron Pharmaceuticals, cutting an estimated $189M.
- Pacer Advisors fully exited Rithm Capital in Q4 2022, selling an estimated $118M.
- Pacer Advisors's ten largest holdings make up 20% of its $19.5B portfolio in Q4 2022.
- Pacer Advisors opened 1,285 new positions and closed 56 in Q4 2022.
- Pacer Advisors's portfolio value rose 36% quarter-over-quarter to $19.5B.
Based on Pacer Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.